首页
登录
职称英语
Growing concerns over the safety and efficacy of anti-depressant drugs prescr
Growing concerns over the safety and efficacy of anti-depressant drugs prescr
游客
2024-11-30
8
管理
问题
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress and the New York state attorney general. Now they’re becoming the catalyst for calls to reform the way clinical trials of all drugs are reported.
Pressure is already causing some changes within the pharmaceutical industry. And it has put the US Food and Drug Administration (FDA), which approves new drugs, in the hot seat. If reforms are carried out, they could bring an unprecedented level of transparency to drug research.
The solution now under consideration: a public database, or registry, of drug trials, where companies would post the results of those trials.
In congressional testimony Thursday, a spokesman for the American Medical Association endorsed the registry and said it should include information on each trial’s purpose and objective, its design, and the dates it begins and ends. If the trial is not completed, the registry should include an explanation.
While drug companies have been eager to make public any positive results of their trials, recent revelations suggest they’ve balked at divulging tests when the results are not what they’d hoped to see. The furor has centered around the use of anti- depressants on children.
The industry has begun to make some moves to address the concerns about drug trials. Drug companies have agreed to set up a voluntary system of posting their drug trials on the Internet. But that seems unlikely to satisfy some members of Congress, who are expected to ! ntroduce legislation to establish a mandatory drug registry.
Last week, editors of a dozen influential medical journals announced that they would begin requiring drug companies to post a drug trial in a public database prior to accepting an article about it. Doctors rely on these articles to make treatment choices. The editors hope that the registry will force unfavorable drug studies, before kept secret, into the open.
Medical journals already had been tightening up on the authorship of their articles, insisting that authors declare if they had any conflicts of interest, such as any financial or other ties to the drug company, says Daniel Callahan, a director at the Hastings Center, a nonprofit bioethics research institute in Garrison, N.Y.
Information from previously undisclosed clinical trials could lower prices, reduce the number of badly designed trials, and help doctors considering the use of a drug for a non-approved purpose to know why it hash’ t been approved for that use.
Antidepressant drugs "have some serious side effects ... that seem to be much more common than people realize.., much more common than you might think from seeing drug ads and from reports on drug studies," says Joel Gurin, executive vice president of Consumer Reports. His magazine just finished a survey of readers showing a "dramatic shift from talk therapy to drug therapy for mental health problems" during the
past decade. In 1995, less than half of people getting mental health treatment —40 percent- got drug therapy. Today 68 percent receive drug treatment, Mr. Gurin says.
Some studies coming to light show that antidepressants work no better than placebos. Even better than merely registering drug trials, Caplan (director of the Center for Bioethics at the University of Pennsylvania in Philadelphia) suggests, would be to require that a new drug not only be "safe and do what it’ s sup- posed to do", but that it do it as well or better than other drugs already on the market. That, he says, would help push research into new areas and save money. [br] Which of the following statements is true about drug companies?
选项
A、They are very transparent in reporting the results of the tests.
B、They have reached an agreement with Congress.
C、Sometimes they hold back unfavorable results.
D、They are willingly to post a drug trial in a public database.
答案
C
解析
下面哪一项关于药品公司的论述是正确的?第五段提到“recent revelations suggest they’ve balked at divulging tests when the results are not what they’d hoped to see”即,药品公司会隐瞒那些对自己不利的结果。
转载请注明原文地址:https://tihaiku.com/zcyy/3867729.html
相关试题推荐
Intheearly1450’sculturalchangeinEuropefueledagrowingneedforther
Intheearly1450’sculturalchangeinEuropefueledagrowingneedforther
Intheearly1450’sculturalchangeinEuropefueledagrowingneedforther
Growingconcernsoverthesafetyandefficacyofanti-depressantdrugsprescr
Growingconcernsoverthesafetyandefficacyofanti-depressantdrugsprescr
Growingconcernsoverthesafetyandefficacyofanti-depressantdrugsprescr
WhenIwasgrowingup,Iwasembarrassedtobeseenwithmyfather.Hewass
WhenIwasgrowingup,Iwasembarrassedtobeseenwithmyfather.Hewass
WhenIwasgrowingup,Iwasembarrassedtobeseenwithmyfather.Hewass
WhenIwasgrowingup,Iwasembarrassedtobeseenwithmyfather.Hewass
随机试题
Ifaandbarethetwosolutionsoftheequationx2-5x+4=0,whatistheva
直接头脑风暴法的提出者是A.奥斯本 B.西蒙 C.泰罗弗 D.鲁姆
在图示xy坐标系下,单元体的最大主应力σ1大致指向( )。 A、第一象
如图b)所示电源与图a)所示电路等效,则计算Us和R0的正确算式为:
女,65岁,因胃癌行全胃切除术,术后5天突感左下肢肿胀,轻微痛。术后一直卧床,有
女;2岁,以发热2天伴皮肤瘀点,瘀斑8小时入院。体检:脑膜刺激征(+),脑脊液检
关于变态反应性接触性皮炎的说法,哪项不正确A.皮炎的轻重与个体敏感性有关 B.
王小姐,女,18岁,因面临考试,担心考试不及格,每天只睡眠5个小时,一周后,出现
加工贸易企业从事加工出口业务中,因不可抗力原因造成损毁导致无法复出口的保税进口料
下列关于定价策略正确的是()A.交易折扣的多少岁行业与产品的不同而有所区别
最新回复
(
0
)